Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFair Oaks Inc Regulatory News (FAIR)

Share Price Information for Fair Oaks Inc (FAIR)

Share Price is delayed by 15 minutes
Get Live Data
4.02    -0.02 (-0.50%)
Bid:
3.94
Ask:
4.10
Spread: 0.16 (4.061%)
Market Cap: €233.62m
FAIR Live PriceLast checked at - London Stock Exchange

Intraday Fair Oaks Inc Share Chart

Portfolio Update

7 Jun 2019 14:29

RNS Number : 5672B
Fair Oaks Income Limited
07 June 2019
 

 

Fair Oaks Income Limited

7 June 2019

 

FAIR OAKS INCOME LIMITED (the "Company")

 

(Incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 58123 and registered as a Registered Closed-ended Collective Investment Scheme with the Guernsey Financial Services Commission)

 

PORTFOLIO UPDATE

 

 

Fair Oaks Income Limited (the "Company") is pleased to announce that FOMC II LP ("Master Fund II") has entered into binding contracts to acquire, in the primary market, €27 million notional of equity notes in Fair Oaks Loan Funding I, a new CLO backed by a portfolio of European broadly syndicated secured loans.

 

The manager of this CLO's portfolio is Fair Oaks Capital Limited, the investment advisor to the Company and Master Fund II.

 

This CLO's current target portfolio has a principal value of €325 million across an expected 133 unique bank loan issuers, with an expected weighted average exposure per issuer of approximately 0.62%.

 

The potential total return for this investment, as estimated by the general partner of Master Fund II, is between 14% and 15% per annum (see Note 1).

 

In the same week, two existing investments were refinanced. Master Fund I refinanced the liabilities of Elevation CLO 2015-4 (formerly called Arrowpoint CLO 2015-4), reducing its weighted average cost of funding by 0.66%. Cycad Investments LP (in which Master Fund II is invested) refinanced the liabilities of Elm CLO 2014-1, reducing its weighted average cost of funding by 0.47%.

 

LEI: 2138008KETEC1WM5YP90

 

Enquiries:

 

Fair Oaks Income Limited

Email: contact@fairoaksincome.com

Web: www.fairoaksincome.com

 

Fair Oaks Capital Limited

Investor Relations

DDI: +44 (0) 20 3034 0400

Email: ir@fairoakscap.com

 

Praxis Fund Services Limited

Ben Le Prevost

DDI: +44 (0) 1481 755524

Email: Ben.LePrevost@praxisifm.com

  

Numis Securities Limited

Nathan Brown, Corporate Broking

DDI: +44 (0) 20 7260 1426

Email: n.brown@numis.com 

 

 

 

Fair Oaks Income Limited

 

Fair Oaks Income Limited is a registered closed-ended investment company incorporated in Guernsey. The Company was admitted to trading on the Specialist Fund Market of the London Stock Exchange (now the Specialist Fund Segment of the Main Market of the London Stock Exchange) on 12 June 2014.

 

The investment policy of the Company is to invest (either directly and/or indirectly through FOMC II LP) in US and European CLOs or other vehicles and structures which provide exposure to portfolios consisting primarily of US and European floating-rate senior secured loans and which may include non-recourse financing.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBXGDLUDGBGCR
Date   Source Headline
19th May 20207:00 amRNSNet Asset Value(s)
1st May 20208:00 amRNSTotal Voting Rights
27th Apr 20204:00 pmRNSNotice of AGM
27th Apr 20207:00 amRNSIssue of Shares
24th Apr 20207:00 amRNSIssue of Shares
22nd Apr 202011:07 amRNSSecond Price Monitoring Extn
22nd Apr 202011:01 amRNSPrice Monitoring Extension
17th Apr 20203:00 pmRNSAnnual Financial Report
17th Apr 20207:00 amRNSIssue of Shares
15th Apr 20207:00 amRNSNet Asset Value(s)
2nd Apr 20209:05 amRNSSecond Price Monitoring Extn
2nd Apr 20209:00 amRNSPrice Monitoring Extension
1st Apr 202011:05 amRNSSecond Price Monitoring Extn
1st Apr 202011:02 amRNSPrice Monitoring Extension
1st Apr 20209:06 amRNSSecond Price Monitoring Extn
1st Apr 20209:01 amRNSPrice Monitoring Extension
31st Mar 20202:09 pmRNSSecond Price Monitoring Extn
31st Mar 20202:01 pmRNSPrice Monitoring Extension
31st Mar 202011:07 amRNSSecond Price Monitoring Extn
31st Mar 202011:01 amRNSPrice Monitoring Extension
30th Mar 202011:06 amRNSSecond Price Monitoring Extn
30th Mar 202011:01 amRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSCompany Update
20th Mar 20207:00 amRNSNet Asset Value(s)
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:38 pmRNSPrice Monitoring Extension
19th Mar 20202:07 pmRNSSecond Price Monitoring Extn
19th Mar 20202:04 pmRNSPrice Monitoring Extension
16th Mar 20203:21 pmRNSDividend Currency Election
3rd Mar 202010:06 amRNSDividend Declaration
19th Feb 20207:00 amRNSNet Asset Value(s)
18th Feb 20203:02 pmRNSDividend Currency Election
6th Feb 20209:40 amRNSDividend Declaration
23rd Jan 20209:42 amRNSHolding(s) in Company
22nd Jan 20205:25 pmRNSReinvestment of Management Fees
20th Jan 20203:04 pmRNSDividend Currency Election
16th Jan 20207:00 amRNSNet Asset Value(s)
15th Jan 20204:42 pmRNSHolding(s) in Company
9th Jan 20208:30 amRNSDividend Declaration
19th Dec 20197:00 amRNSNet Asset Value(s)
18th Dec 20197:00 amRNSReplacement re Extension to Master Fund Maturity
17th Dec 20195:00 pmRNSExtension to Master Fund Commitment Period
17th Dec 20199:34 amRNSHolding(s) in Company
17th Dec 20199:29 amRNSDividend Currency Election
3rd Dec 20192:46 pmRNSDividend Declaration
19th Nov 20197:00 amRNSDividend Currency Election
14th Nov 20197:00 amRNSCompany Update
14th Nov 20197:00 amRNSNet Asset Value(s)
4th Nov 201910:25 amRNSDividend Declaration
1st Nov 20198:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.